Status:
COMPLETED
PETACC-8 miR-31-3p and miR-31-5p Ancillary Study
Lead Sponsor:
IntegraGen SA
Collaborating Sponsors:
Federation Francophone de Cancerologie Digestive
Exystat
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18-74 years
Phase:
PHASE3
Brief Summary
This is a prospective-retrospective study to determine if the expression of the miRNA's miR-31-3p and miR-31-5p are prognostic of patient outcomes or predictive of the benefit from anti-EGFR therapy i...
Eligibility Criteria
Inclusion
- Patient included in PETACC08 study
- Signed informed consent for translational study
- FFPE tumor sample available for miR-31-3p and miR-31-5p expression testing
Exclusion
- Patient who have withdrawn their consent for PETACC08 and/or for PETACC08 translational study
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2016
Estimated Enrollment :
1808 Patients enrolled
Trial Details
Trial ID
NCT03362684
Start Date
November 1 2005
End Date
June 30 2016
Last Update
December 5 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.